Americas · Markets & Finance · BNN Bloomberg

Knight Therapeutics Announces Launch of TAVALISSE® in Brazil

Published by BNN Bloomberg · Canada 10 h ago

Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today the launch of TAVALISSE® (fostamatinib disodium hexahydrate) in…

Read the full article on BNN Bloomberg Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bnnbloomberg.ca)

Also worth reading

Financial Post

Matthew Lau: There are some cultural battles business does need to fight

Ámbito

Inflación de septiembre 2026: las consultoras anticipan una nueva aceleración y alimentos vuelve a presionar

Valor Econômico

Banco gosta de trabalhar com juros abaixo de dois dígitos, o que permite impulsionar a economia, diz CEO do Itaú

Les Affaires

À surveiller: Saputo, BMW et Rogers

Les Affaires Bourse

À surveiller: Saputo, BMW et Rogers

Bloomberg Línea

Knight Therapeutics Announces Launch of TAVALISSE® in Brazil

Share

Also worth reading

Matthew Lau: There are some cultural battles business does need to fight

Inflación de septiembre 2026: las consultoras anticipan una nueva aceleración y alimentos vuelve a presionar

Banco gosta de trabalhar com juros abaixo de dois dígitos, o que permite impulsionar a economia, diz CEO do Itaú

À surveiller: Saputo, BMW et Rogers

À surveiller: Saputo, BMW et Rogers

Gobierno de Milei emite deuda en pesos para cancelar pagos pendientes de obra pública